Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

Currently, treatment allocation of patients with Mantle Cell Lymphoma (MCL) is mainly based on age and medical fitness. The combined MCL International Prognostic Index (MIPI-c) allows to predict prognosis using clinical factors (MIPI) and the Ki-67 index. However, high p53 expression as surrogate fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheubeck, Gabriel, Jiang, Linmiao, Hermine, Olivier, Kluin-Nelemans, Hanneke C., Schmidt, Christian, Unterhalt, Michael, Rosenwald, Andreas, Klapper, Wolfram, Evangelista, Andrea, Ladetto, Marco, Jerkeman, Mats, Ferrero, Simone, Dreyling, Martin, Hoster, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457193/
https://www.ncbi.nlm.nih.gov/pubmed/37495776
http://dx.doi.org/10.1038/s41375-023-01977-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457193/
https://www.ncbi.nlm.nih.gov/pubmed/37495776
http://dx.doi.org/10.1038/s41375-023-01977-y

Ejemplares similares